0001209191-17-025700.txt : 20170405
0001209191-17-025700.hdr.sgml : 20170405
20170405165547
ACCESSION NUMBER: 0001209191-17-025700
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170403
FILED AS OF DATE: 20170405
DATE AS OF CHANGE: 20170405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chodakewitz Jeffrey
CENTRAL INDEX KEY: 0001610876
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 17743219
MAIL ADDRESS:
STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC.
STREET 2: 480 ARSENAL ST., SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-04-03
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001610876
Chodakewitz Jeffrey
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP GMDA, CMO
Common Stock
2017-04-03
4
M
0
2291
73.51
A
124802
D
Common Stock
2017-04-03
4
S
0
1491
108.50
D
123311
D
Common Stock
2017-04-03
4
S
0
600
109.32
D
122711
D
Common Stock
2017-04-03
4
S
0
200
110.09
D
122511
D
Stock Option (Right to Buy)
73.51
2017-04-03
4
M
0
2291
0.00
D
2024-01-01
Common Stock
2291
18334
D
Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1.
Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $108.50 (range $108.07 to $108.84).
Open market sales reported on this line occurred at a weighted average price of $109.32 (range $109.09 to $109.70).
The option vests in 16 quarterly installments from 01/02/2014.
Omar White, Attorney-In-Fact
2017-04-05